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rRNA microbial analysis. Microbial signature species, dis-
criminating between the presence and absence food allergy, 
were selected by elastic net regression. Results: Eighty-two 
children with AD (39 girls) with a median age of 2.5 years, and 
20 of whom were diagnosed with food allergy, provided fe-
cal samples. Food allergy to peanut and cow’s milk was the 
most common. Six bacterial species from the fecal microbi-
ome were identified, that, when combined, distinguished 
between children with and without food allergy: Bifidobac-
terium breve, Bifidobacterium pseudocatenulatum, Bifidobac-
terium adolescentis, Escherichia coli, Faecalibacterium praus-
nitzii, and Akkermansia muciniphila (AUC 0.83, sensitivity 
0.77, specificity 0.80). Conclusions: In this pilot study, we 
identified a microbial signature in children with AD that dis-
criminates between the absence and presence of food al-
lergy. Future studies are needed to confirm our findings.
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Abstract
Background: Exposure to microbes may be important in the 
development of atopic disease. Atopic diseases have been 
associated with specific characteristics of the intestinal mi-
crobiome. The link between intestinal microbiota and food 
allergy has rarely been studied, and the gold standard for 
diagnosing food allergy (double-blind placebo-controlled 
food challenge [DBPCFC]) has seldom been used. We aimed 
to distinguish fecal microbial signatures for food allergy in 
children with atopic dermatitis (AD). Methods: Pediatric pa-
tients with AD, with and without food allergy, were included 
in this cross-sectional observational pilot study. AD was di-
agnosed according to the UK Working Party criteria. Food 
allergy was defined as a positive DBPCFC or a convincing 
clinical history, in combination with sensitization to the rel-
evant food allergen. Fecal samples were analyzed using 16S 
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Introduction
The worldwide prevalence of atopic disease has been 
increasing in recent decades [1]. There is no clear reason 
for this observed increase in prevalence, but reduced ear-
ly-life exposure to different microbes is thought to be a 
contributing factor [2–4]. Microbial colonization of the 
human intestine during infancy is important for the mat-
uration of the immune system [5, 6]. Intestinal microbi-
ota can regulate metabolic and inflammatory responses 
and also modulate changes in the intestinal barrier. Sev-
eral studies have shown associations between the intesti-
nal microbiota and the subsequent development of atop-
ic disease, including atopic dermatitis (AD), asthma, or 
rhinitis. However, few studies have investigated a specific 
link between the patterns of intestinal microbiota and 
food allergy. Furthermore, the gold standard for diagnos-
ing food allergy (double-blind placebo-controlled food 
challenge [DBPCFC]) has rarely been used [7].
The microbiome can be considered a complex ecosys-
tem where various species interact and group-based cor-
relations have been identified [5]. Therefore the symbio-
sis of the different bacterial species and their patterns 
should be taken into account in data analysis. To be able 
to identify individual species and take the existing struc-
tures within the microbiome into account, advanced sta-
tistical modeling techniques are needed. Furthermore, 
the assessment of microbial diversity with molecular se-
quencing techniques, as opposed to culture-based tech-
niques, reveals greater diversity and has shown the im-
portance of uncultured species [8].
We hypothesized that children have distinct microbial 
patterns in their fecal microbiome that are associated 
with a clinical diagnosis of food allergy. In this cross-sec-
tional pilot study, we aimed to identify microbial species 
in children with AD, using 16S rRNA microbial analysis 
followed by the statistical elastic net regression approach. 
Methods
Study Design and Participants 
Children with AD who were treated in the outpatient clinic of 
the Wilhelmina Children’s Hospital of the University Medical 
Center Utrecht participated in this cross-sectional pilot study. In-
clusion criteria were: a diagnosis of AD, an age of 0–18 years, pa-
rental ability to answer Dutch questionnaires, and the availability 
of a fecal sample for microbiome analysis. All study partic- 
ipants participated in a randomized controlled trial that com- 
pared shared medical appointments with individual consultations 
(ISRCTN08506572). The medical ethical committee of the Univer-
sity Medical Center Utrecht approved the study and written in-
formed consent was obtained for all participants. Clinical history 
and serum samples were taken on the same day, fecal samples were 
provided within the next days, and a DBPCFC was planned to take 
place within months. 
Assessment of AD and Food Allergy
AD was diagnosed according to the criteria of Williams et al. [9]. 
AD severity was estimated using the self-administered eczema area 
and severity index (SA-EASI) by the research nurse [10]. Sensitiza-
tion was determined by the level of specific IgE against common 
food allergens (hen’s egg, cow’s milk, peanut, hazelnut, fish, wheat, 
and soy). Both total and specific IgE were measured according to the 
manufacturer’s protocol (Phadia, Uppsala, Sweden). A diagnosis of 
asthma or allergic rhinitis was based on the clinical history. 
Food allergy was defined as a positive DBPCFC or a convincing 
clinical history, in combination with sensitization to a specific 
food, or, in the case of peanut allergy, a sensitization to Ara h 2 
above the defined cut-off level in our clinic (5.17 kU/L) [11]. A 
convincing clinical history was defined as a reported type I allergic 
reaction with acute symptoms within 2 h after the ingestion of the 
food. DBPCFC was considered positive and was then terminated 
when persistent objective symptoms occurred (e.g., vomiting, gen-
eralized urticaria, wheezing, or a significant drop in blood pres-
sure), or after subjective symptoms (oral allergy symptoms, nau-
sea, and abdominal discomfort) on 3 subsequent doses, or the oc-
currence of a severe subjective symptom (abdominal pain/nausea 
with discomfort) lasting for >45 min, according to the interna-
tional protocol [12]. Late reactions were assessed using follow-up 
by telephone the next day. 
Fecal Samples
Fecal samples were collected at home and sent to the labora-
tory using the regular postal service. The samples were aliquoted 
and frozen at –20 ° C for further processing.
Fecal DNA Isolation
Approximately 150 mg of fecal material was directly trans-
ferred to the DNA isolation plate. Next, 0.5 mL phenol solution 
(pH 8.0; catalogue P4557, Sigma-Aldrich, St Louis, MO, USA) was 
added and the cells in the samples were mechanically disrupted by 
bead-beating twice for 3 min with a 96-well-plate BeadBeater (Bio-
spec Products, Bartlesville, OK, USA). Samples were centrifuged 
at 4,000 rpm for 10 min to separate the aqueous and phenolic phas-
es. The aqueous phase was transferred to a 96-well plate, and DNA 
was purified with the AGOWA mag Mini DNA isolation kit 
(AGOWA, LGC Genomics, Berlin, Germany) in accordance with 
the manufacturer’s recommendations. After elution, the total bac-
terial load in each sample was assessed by quantitative PCR using 
a universal bacterial primer-probe set [13].
16S rDNA Illumina Sequencing
Analysis of the fecal microbiome composition was performed 
by mass sequencing of the V4 hypervariable region of the 16S 
rRNA gene on the Illumina MiSeq sequencer (Illumina, San Diego, 
CA, USA). Barcoded DNA fragments spanning the archaeal and 
bacterial V4 hypervariable region were amplified with a standard-
izing level of template DNA (100 pg) to prevent overamplification. 
These amplicons, generated using adapted primers 533F and 806R, 
were bidirectionally sequenced using the MiSeq system [14]. Pre-
processing and classification of sequences was performed using 
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modules implemented in the mothur v1.20.0 software platform 
[15]. The relative abundance of unique sequences was calculated 
for every fecal sample. The dataset was transformed using a zero 
mean unit variance transformation for subsequent statistical anal-
yses. The V4 amplicon of the 16S rRNA encoding gene allows for 
the discrimination of several Bifidobacteria species, but not all 
[16]. Therefore, relevant sequences were blasted in the Ribosomal 
Database Platform (RDP) to determine a more accurate species 
level. Shannon diversity indices were calculated to describe the mi-
crobial diversity. 
Statistical Analysis
Descriptive statistics were used to describe patient characteris-
tics. Nonparametric tests were used to compare the groups with 
and without a confirmed food allergy. 
Elastic Net Regression
Bacterial signature species discriminating between the absence 
and presence of food allergy were selected using elastic net regres-
sion. This is a statistical machine-learning approach, applicable to 
large-scale, structured, and higher-dimensional data. The method 
is regularization-based and combines the advantages of LASSO 
regression (sparsity, retaining the feature selection property of re-
ducing coefficients to exact zero values provided by LASSO) and 
ridge regression (smoothness, a tendency of shrinking coefficients 
to small values for correlated trending towards each other) [17, 
18]. All species present and the correlations between them are tak-
en into account, which allows for the identification of patterns of 
species rather than individual species [19]. Using elastic net regres-
sion, it is not possible to correct for other confounding factors 
which is common in other types of regression analyses used in 
medical statistics [19].
Randomization Test and Receiver Operating Characteristics/
Area under the Curve
A randomization test was conducted to test the statistical valid-
ity of the results obtained with elastic net regression. ROC/AUC 
(receiver operating characteristics/area under the curve) scores 
were generated multiple times after randomly reshuffling the food 
allergy diagnoses, while keeping the corresponding microbial pro-
files intact [20]. The dataset was cross-validated by randomly hid-
ing 30% of the children from the model and evaluating the predic-
tion quality on that group. The predictive accuracy of the classifi-
cation model was measured with the ROC/AUC score, using a 
critical value of 0.05. 
SPSS v22 (IBM, Armonk, NY, USA) was used for descriptive 
data analysis. GraphPad Prism v6.01 (GraphPad Software, La Jolla, 
CA, USA) was used for providing graphs and figures. All other 
statistical analyses were performed using numerical Python v2.7 
(Python Software Foundation, https://www.python.org).
Results
AD and Food Allergy 
We included 82 children in this cross-sectional pilot 
study. There were no significant differences regarding sex 
or age between the children who were included and those 
who were not (data not shown). All 82 children were di-
agnosed with AD, 62 children had no food allergy, and 20 
children had a confirmed food allergy (Table 1). Of the 62 
children without food allergy, almost half were sensitized 
to common food allergens without having symptoms of 
food allergy after ingestion of the food. In the 20 children 
with a food allergy, peanut allergy and cow’s milk allergy 
were the most common (Table 2). Multiple food allergies 
were found in 2 children. On average, a DBPCFC was 
performed within 10 months (range 1–27 months) of 
providing the fecal samples. 
Sequence and Microbiota Characteristics
A total of 2,609,478 high-quality sequences were ob-
tained (mean 27,182; range 5,825–105,404 sequences/
Table 1. Patients’ characteristics
AD patients with no
food allergy (n = 62)
AD patients with a confirmed
food allergy (n = 20)
p value
Median age, years 3.0 (0.5–19) 2.2 (0.5–12) 0.606
Females, n 32 (52%) 7 (35%) 0.196
Median SA-EASI 29 (2–84) 46 (0–86) 0.283
Median TARC, pg/mL 1,243 (70–10,000) 2,251 (784–10,000) 0.013
Median total IgE, kU/L 62 (1.9–4,718) 564 (9–10,601) <0.001
Sensitization to any food allergen, n 27 (43%) 20 (100%) <0.001
On an elimination diet for any food, n 19 (31%) 20 (100%) <0.001
Diagnosed with asthma, n 18 (29%) 5 (25%) 0.727
Diagnosed with rhinoconjunctivitis, n 15 (24%) 5 (25%) 0.942
Values in parentheses after median values are min–max. AD, atopic dermatitis; FA, food allergy; SA-EASI, self-administered eczema 
area and severity index (scored by the research nurse); TARC, thymus and activation regulated chemokine.
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sample) that could be assigned to 12 different phyla and 
1,000 unique sequences. The most predominant phy- 
la, based on mean relative abundance, were Firmicutes 
(47%), Actinobacteria (32%), Bacteroidetes (9%), Proteo-
bacteria (8%), and Verrucomicrobia (2%), characteristic 
for the gut microbiome of children [21]. Predominant 
families were Bifidobacteriaceae (28%), Lachnospira- 
ceae (27%), Ruminococcaceae (10%), Enterobacteriaceae 
(5%), Streptococcaceae (4%), and Coriobacteriaceae 
(3.5%). Median Shannon diversity indices calculated for 
the group of children with and without a food allergy 
were 3.61 (IQR 1.16) and 3.93 (IQR 1.09), respectively 
(p = 0.430). 
Identification of Microbial Biomarkers Related to 
Food Allergy
We identified 6 microbial species from 4 families that, 
together, discriminate between the absence and presence 
of food allergy in children with AD: Bifidobacterium 
breve, Bifidobacterium pseudocatenulatum, Bifidobacte-
rium adolescentis (Bifidobacteriaceae), Escherichia coli 
(Enterobacteriaceae), Faecalibacterium prausnitzii (Ru-
minococcaceae), and Akkermansia muciniphila (Verru-
comicrobiaceae). On the species level, B. breve/longum 
and B. pseudocatenulatum/ catenulatum/ gallicum/ kashi-
wanohense could not be distinguished after additional 
blasting in the RDP, and are referred to as B. breve and 
B. pseudocatenulatum throughout the paper. 
Figure 1 shows the relative abundance of the 6 identi-
fied signature species. The fecal microbiome of children 
with AD and food allergy harbored relatively more E. coli 
and B. pseudocatenulatum, and less B. breve, B. adolescen-
tis, F. prausnitzii, and A. muciniphila than children with 
AD without food allergy. The randomization test indi-
cates that the combination of these 6 species is signifi-
cantly different in the 2 groups (p = 0.001), even though 
the relative abundance of some single species may seem 
Table 2. The number of children with confirmed food allergies
A confirmed FAa A positive DBPCFCb An obvious clinical
history (only)
FA was predicted, based on elevated
sIgE to Ara h 2 (>5.17 kU/L)c
Peanut 8 (40%) 3 (15%) 1 (5%) 4 (20%)
Hazelnut 1 (5%) 1 (5%)
Cow’s milk 8 (40%) 6 (30%) 2 (10%)
Hen’s egg 4 (20%) 3 (15%) 1 (5%)
Other nuts 2 (10%)
Cashew
Pistachio
1 (5%)
1 (5%)
Soy 0
Fish/shrimp 0
Total 20 (100%)
FA, food allergy. a Multiple FAs resulted in multiple entries: 1 patient had a confirmed FA to cow’s milk, peanut, and hen’s egg; 
1 patient had a confirmed FA to hazelnut and hen’s egg. b Including late reactions. c According to Klemans et al. [11].
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Fig. 1. Relative abundance of the microbial signature species in 
children with AD, without AD, and with a confirmed food allergy 
(FA).
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similar on a group level (Fig. 1). Different relative contri-
butions from the single species towards the total distinc-
tive properties are distinguished, with B. breve, B. adoles-
centis, and F. prausnitzii having a greater influence than 
B. pseudocatenulatum, E. coli, and A. muciniphila, ex-
pressed as importance indices based on the elastic net re-
gression (Fig. 2). The overall predictive accuracy of the 
classification model (AUC) is 0.83 (Fig. 3), with a sensi-
tivity of 0.77 and a specificity of 0.80. Online supplemen-
tary Figures S1–S3 (for all online suppl. material, see 
www.karger.com/doi/10.1159/000484897) show the rela-
tive abundance of the signature species, the distribution 
of the 30 most abundant species, and the individual dis-
tribution of the signature species. 
Discussion 
We analyzed the fecal microbiome of children with 
AD with or without a concomitant food allergy, and 
found that a combination of 6 microbial species, includ-
ing E. coli, F. prausnitzii, A. muciniphila, and 3 types of 
Bifidobacteria, discriminates between the presence and 
absence of food allergy in children with AD (p = 0.001). 
The fecal microbiome of children with AD and food al-
lergy harbored relatively more E. coli and B. pseudoca-
tenulatum, and less B. breve, B. adolescentis, F. prausnit-
zii, and A. muciniphila than that of children with AD 
without food allergy. We found no differences in micro-
bial diversity (according to the Shannon index) between 
the children with and without food allergy. 
This is the first pilot study that identifies microbial sig-
natures specific for food allergy in a group of children 
with AD by making use of 16S rRNA sequencing tech-
niques to generate unique sequences, followed by statisti-
cal machine-learning approaches. Previous studies main-
ly used culture-based techniques to analyze the intestinal 
microbiome or used 16S rRNA sequencing techniques, 
but subsequently simplified the data in the analysis stage, 
by focusing on key groups of species or analyzing the data 
on a family or genus level. However, this approach leads 
to less detailed information. For example, the identifica-
tion of B. pseudocatenulatum, B. breve, and B. adolescen-
tis would not have been possible when analyzing the data 
on a family level. Furthermore, the elastic net regression 
model takes group-based species interactions into ac-
count. Since interactions between species in the gut mi-
crobiome occur, this approach may lead to biologically 
more reliable results than with other statistical regression 
approaches [22]. 
Our study demonstrates that children with AD and a 
food allergy had significantly less F. prausnitzii and A. 
muciniphila than children with AD without a food aller-
gy. F. prausnitzii and A. muciniphila have been gaining 
interest more recently because of their immune-modula-
tory properties and possible role in mucosal tolerance. F. 
prausnitzii is the most common abundant species in the 
human intestinal microbiome. Its decreased abundance 
has been associated with several diseases, including aller-
gic disease and AD [23–25]. F. prausnitzii is the main pro-
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ducer of butyrate in the colon, an energy source for co-
lonocytes with important anti-inflammatory effects. It 
also secretes anti-inflammatory molecules that directly 
modulate the host immune system, stimulates IL10-pro-
ducing regulatory T cells and is involved in the balance 
between effector and regulatory T cells [26, 27]. A. mu-
ciniphila is also involved in the immunological homeo-
stasis of the gut mucosa and gut barrier function, via an 
outer membrane protein that stimulates IL10 production 
[28]. 
Bifidobacteria and E. coli have been associated with 
food allergy and AD in other studies [29]. Less Bifidobac-
teria in the feces of children with a confirmed cow’s milk 
allergy has been reported [30]. Cow’s milk allergy was a 
common food allergy in our study population, so it is pos-
sible that our results regarding B. breve and B. adolescen-
tis were mainly contributed by the children allergic to 
cow’s milk. Furthermore, we found an increased relative 
abundance of E. coli in the food-allergic group. E. coli has 
previously been associated with the diagnosis of AD, with 
increasing numbers of E. coli further increasing this risk 
[31]. The children in our study were all diagnosed with 
AD with varying severity. However, the higher levels of 
thymus and activation regulated chemokine (TARC) in 
the food-allergic group suggest increased AD severity 
compared to the nonallergic group. This raises the pos-
sibility that the selected biomarkers also correlated with 
AD severity, which fits with the observation that the prev-
alence of food allergy is higher in children with greater 
disease severity [32]. 
All the microbial species resulting from our analysis 
have previously been correlated with atopic disease in 
other studies. This might raise the question of whether we 
are looking at a food allergy-specific microbial profile or 
a profile that is related to atopic diseases in general, as 
most of these children have or will develop other comor-
bidities within the atopic syndrome. Atopic disease has 
been defined differently in previous studies. In our study, 
all children were clinically diagnosed with AD and, in ad-
dition, asthma and allergic rhinitis were confirmed or 
ruled out based on the child’s clinical history. Food al-
lergy was diagnosed based on DCPCFC in the majority of 
patients. Post hoc analyses showed no significant differ-
ences between the group with and the group without food 
allergy with regard to other atopic diagnoses, suggesting 
that the species identified species indicate food allergy 
rather than general atopy. 
Our study supports the hypothesis that, in children 
with AD, the intestinal microbiome differs in children 
with and without food allergy. Intestinal microbiota regu-
late the development of functions of a diverse range of T 
cells, such as Th17, Th1, Th2, and regulatory T cells, and 
also modulate innate lymphoid cells [33, 34]. By modify-
ing the response of gut-associated lymphoid tissues, in-
testinal microbiota may influence the development of 
oral tolerance [35]. A recent study on humans showed 
that delayed colonization with Bacteroidetes is associated 
with a poorly developed Th1 response, which is impor-
tant in immune tolerance [36]. It is also possible that dis-
ruption of the gut microbiome alters the epithelial integ-
rity of the gut, thereby increasing the risk of allergic sen-
sitization through the direct uptake of allergens [7]. 
However, the exact mechanisms by which the intestinal 
microbiome influences food allergy are not elucidated 
yet. Furthermore, it is not clear whether a change in the 
microbiome precedes or follows the development of food 
allergy. 
Long-term dietary intake affects gut microbiome com-
position, together with host genetics, age, medication, 
and general lifestyle [37]. Our study population con-
sumed a Western diet. In addition to this, established 
food allergies lead to an elimination diet, where the spe-
cific food allergen is excluded from the general diet. We 
cannot exclude the possibility that an elimination diet 
where one particular food is excluded from the diet would 
also leads to detectable changes in the fecal microbial 
composition, as has been demonstrated where there is an 
increased consumption of specific foods [38]. However, 
in our study, one-third of the children in the group with-
out food allergy also reported being on an elimination 
diet for a specific food, for various reasons. Furthermore, 
dietary intake varies according to personal preference. 
Therefore, it is unlikely that the observed microbial dif-
ferences can be solely attributed to the dietary differences. 
Besides a self-reported elimination diet, dietary intake 
was not further assessed in this study because it is very 
difficult to assess accurately.
A limitation of our cross-sectional study was the het-
erogeneity of the study population. All of the children 
were diagnosed with AD, with varying disease severity, 
age, and food allergies. We did not include any healthy 
controls. As was to be expected in children, cow’s milk 
allergy and peanut allergy were the most common food 
allergies in our study population, so it is possible that our 
results were influenced by the contribution of these par-
ticular food allergies. It is also plausible that distinct mi-
crobes are associated with different food allergies [29]. 
Due to a lack of statistical power, we were unable to select 
signature species for specific food allergies. Variables that 
are known to influence the gut microbiome, such as the 
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use of antibiotics, birth via caesarean section, or breast-
feeding, were not assessed in this study [7]. Furthermore, 
because of the time between the acquisition of the fecal 
sample and the DBPCFC, transient food allergies could 
have resulted in the misclassification of some children 
with cow’s milk allergy and hen’s egg allergy. 
Our findings are based on a study population of chil-
dren with AD from an academic center. Identifying the 
microbes that are related to food allergy may help in the 
development of future interventions. However, future 
studies are needed to confirm our findings in the commu-
nity, preferably with prospective study designs using well-
defined patient populations to further explore the poten-
tial of the fecal microbial colonization patterns associated 
with specific food allergies in children with AD. Control 
groups should also be included, i.e., children with food al-
lergy without AD, or with severe “extrinsic” AD without 
food allergy. These groups should be of sufficient size to 
allow for the stratification of different food allergies.
Conclusion
In this pilot study, we identified a microbial signature 
in children with AD that discriminates between the ab-
sence and presence of food allergy. Future studies are 
needed to confirm our findings.
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